Isehara, Japan

Naoshi Ohta

This inventor holds 1 USPTO granted patent. Top assignees: Riken Corporation, Tokai University Educational System. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoshi Ohta. Retrieved from https://idiyas.com/inventor/naoshi-ohta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoshi Ohta: Innovator in Joint Disease Treatment

Introduction

Naoshi Ohta is a notable inventor based in Isehara, Japan. He has made significant contributions to the field of medical treatments, particularly in the area of joint diseases. His innovative approach aims to improve the quality of life for individuals suffering from conditions such as osteoarthritis.

Latest Patents

Ohta holds a patent for a combined preparation for treating joint diseases. The objective of this invention is to enable the repair and regeneration of articular cartilage, which has been a challenge for conventional therapies. The patent describes a formulation that allows for the simultaneous, separate, or sequential administration of hyaluronic acid and an animal mucin-type glycoprotein. This formulation is designed to be a safe and cost-effective agent for treating joint diseases.

Career Highlights

Throughout his career, Naoshi Ohta has worked with reputable organizations, including Riken Corporation and Tokai University Educational System. His work in these institutions has allowed him to further his research and develop innovative solutions for joint health.

Collaborations

Ohta has collaborated with notable colleagues such as Kiminori Ushida and Koji Kihira. Their combined expertise has contributed to advancements in the treatment of joint diseases.

Conclusion

Naoshi Ohta's contributions to the field of joint disease treatment through his innovative patent highlight his commitment to improving patient care. His work continues to inspire advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…